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Abstract 
 
 
 The insecticidal crystal proteins, known as Cry toxins, are naturally derived from 
Bacillus thuringiensis and provide an environmentally safe form of pest control. Though 
these proteins have been studied extensively, little is known regarding their specific 
mechanism of action and any conformational changes associated with this mechanism. In 
an effort to design a mutant Cry1Ab toxin with two individual lysine and cysteine 
residues for fluorophore ligation, this study focuses on the characterization of the 
structural effects of lysine mutagenesis leading to future development of such a toxin. In 
this study, the three lysines of active Cry1Ab toxin are mutated to alanine in different 
combinations, and the structural effects of these mutations are monitored by SDS-PAGE, 
bioassay, and circular dichroism wavelength scanning. Structural analyses have revealed 
that mutation of lysine 490 to alanine results in a toxin with increased protease sensitivity 
that makes isolation of pure, active toxin by the standardized procedure extremely 
difficult. Mutations of the other lysine residues are shown to have a lesser effect on toxin 
structure. The observations of this study contribute to data regarding potential sites on 
Cry1Ab for ligation of functional groups, and the structural and functional effects of 
mutagenesis at these sites.  
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Introduction 
 
 The insecticidal crystal proteins, known as Cry toxins, produced by sporulating 
Bacillus thuringiensis (Bt) have been a subject of intensive research for their potential in 
agricultural applications as biologically derived and biodegradable pesticides. In a time 
when environmental issues, such as the environmentally damaging use of chemical 
pesticides, are receiving much attention, a naturally derived pesticide with minimal 
ecological implications provides a more responsible form of pest control. Each toxin 
within this large family of proteins is typically specific to only one or a few species 
within an order, depending, at least in part, on the aminopeptidase N (APN) and 
cadherin-like receptor types found in the midgut epithelial cells of the target organism 
(1). Typically, the toxin is ingested by a susceptible insect as an insoluble inclusion body 
and is solubilized by the alkaline conditions within the insect’s midgut, where proteolytic 
processing cleaves portions of the carboxy terminus and sometimes also the amino 
terminus (2). In the case of Cry1Ab, this means the processing of a 130 kDa protoxin to a 
65 kDa active toxin through extensive trypsinization of the carboxy terminus and more 
minor processing of the amino terminus. Solubilization and proteolytic processing then 
leads to receptor binding at APN and/or cadherin-like receptors and insertion of the toxin 
into epithelial cell membranes forming ion channels or pores leading to insect death. 
Crystallographic data of the closely related Cry1Aa protein (3) suggests that Cry1Ab has 
a three domain structure. Domain I consists of seven α-helices forming a bundle around 
α-helix 5, and α-helix 1 is believed to be cleaved at some point after or prior to membrane 
insertion (4). Evidence supports that domain I functions primarily in membrane insertion 
and pore formation (5). Domain II takes on a β-prism fold of three β sheets arranged in a 
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Greek key motif and its loop regions have been shown to affect receptor binding (6,7). 
Domain III forms a β-sandwich “jelly roll” topology of two twisted, antiparallel β-sheets 
and is also related to receptor binding (8,9). Figure 1 shows Cry1Ab with its three 
domains and three lysines color coded (based on PDB file 1CIY for Cry1Aa). The 
mechanism and extent of toxin insertion has been a subject of some dispute. Current 
models, such as the “umbrella model” and the “penknife model,” suggest that α-helices 4 
and 5 (the umbrella model) or 5 and 6 (the penknife model) of domain I penetrate the 
epithelial cell membrane to form an ion pore in response to receptor binding, leaving the 
remainder of the toxin outside the membrane (10). Evidence has been found, however, 
that portions of both domains II and III can insert into brush border membrane vesicles, 
suggesting that the extent of membrane insertion may be greater than the above 
mechanisms would allow (11). In summary, though the structure and activities of Cry1Ab 
have been well characterized, the true molecular dynamics of receptor binding, 
membrane insertion, and pore formation have yet to be well characterized. 
 In an effort to shed light on the conformational dynamics of Cry1Ab, this project 
began with the goal of analyzing intramolecular Förster resonance energy transfer 
(FRET) between fluorophores attached to cysteine and lysine residues of the active toxin. 
As the wild type, active toxin contains three lysine residues and no cysteine residues, one 
cysteine would have to be introduced and two lysines removed to provide two distinct 
moieties for fluorophore ligation. In the event that structural and functional analyses of 
such a mutant toxin would show it to be insignificantly perturbed by such mutagenesis 
and labeling, changes in FRET response could quantitatively describe distances between 
structural elements in solution and in response to receptor binding and membrane 
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insertion. After site-directed mutagenesis by PCR with mutagenic primers, purification of 
a mutant toxin revealed the significance of at least one lysine residue on structural 
stability or expression. The significance of lysine residues on the structure and stability of 
Cry1Ab, by necessity, had to be addressed and is the focus of this work. Successive 
mutagenesis of lysine to alanine at residues 403, 478, and 490 provided three single 
mutants, two double mutants (K478A/K490A further referred to as DM1 and 
K478A/K403A further referred to as DM2), and one triple mutant (TM). These are the 
six mutant strains characterized in this study. After isolation of each pure toxin variant, 
structure, stability, and functionality were addressed by SDS-PAGE, bioassay, and 
wavelength scanning circular dichroism. The true value of this study lies in the 
characterization of lysine mutagenesis for the sake of using lysine residues as sites for the 
binding of markers, fluorophores, or other functional groups.  
 
Materials and Methods 
 
 
Site-directed Mutagenesis, Transformation, and Confirmation of Expression 
 
The cry1Ab9-033 gene (12), originally provided by Dr. T. Yamamoto (Sandoz 
Agro Inc., Palo Alto, Calif), was previously inserted into Stratagene’s PBluescript vector, 
and was kindly provided as such by Dr. Manoj S. Nair (Biochemistry Department, The 
Ohio State University). Mutagenesis was carried out by PCR using EMD Biosciences’ 
KOD Hot Start DNA Polymerase and its corresponding reaction components to a 50 µl 
reaction volume. Mutagenic primers were ordered online from Sigma Aldrich. Parental 
DNA was DpnI (1 µl, 20,000 U/ml, New England BioLabs) digested for 1 hour before 
transformation to chemically competent DH5α, prepared by CaCl2 treatment (OD600 of 
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0.4-0.5). Plasmid DNA was purified for sequencing using the QIAGEN QIAprep® Spin 
MiniPrep Kit as described in the manufacturer’s manual.  Positive mutagenesis was 
confirmed by plasmid sequencing at The Ohio State University’s Columbus campus Plant 
Microbe Genomics Facility. Toxin expression was confirmed by 8% polyacrylamide 
SDS-PAGE analysis of cellular or protein extracts. 
 
Large Scale Expression and Purification of Toxin Mutants 
 
 Expression and purification methods were performed based on the procedure 
detailed by Lee et al (7). Cell cultures were grown for 72 hours at room temperature in 
sterile, modified “Terrific Broth” media (0.034 M KH2PO4, 0.144 M K2HPO4, 10 ml 
glycerol / 500 ml broth) with 0.1 mg/ml ampicillin. Cells were pelleted by centrifugation 
for 10 minutes at 8,000 rpm, resuspended in 100 ml sterile lysis buffer (50 mM Tris, 50 
mM EDTA, 15% sucrose, pH 8.0) to which 0.12 g lysozyme was added, and incubated 
with shaking at 37°C overnight. The lysis suspension was then centrifuged as above, the 
pellet was resuspended in 100 ml “Crystal Wash I” (0.5 M NaCl, 2% Triton X-100), and 
the resuspension was sonicated on ice for two, five minute (10 seconds on, 10 seconds 
off) sessions separated by 2 minutes for cooling. This sonicate was then centrifuged as 
above and “washed” by resuspension and centrifugation three times with Crystal Wash I, 
followed by three washes with “Crystal Wash II” (0.5 M NaCl). The resulting washed 
pellet was resuspended and solubilized for 3 hours with mixing at 37°C in 50 mM 
Na2CO3 buffer, pH 10.5, with 2% 2-mercapto ethanol followed by trypsin digestion (2% 
wt/wt) under the same conditions for 30 minutes. Solubilized, trypsined toxin was then 
purified by Q SepharoseTM High Performance ion exchange resin (5 ml, GE Healthcare) 
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and eluted from this resin with 30-50 ml 0.15 M NaCl, 50 mM Na2CO3 buffer, pH 10.5. 
Both flow through and elution fractions were then loaded to a 300 ml column of 
Sephacryl® S-300 HR resin and eluted with 0.5 M NaCl, 50 mM Na2CO3 buffer, pH 
10.5, over 20 ~17.5 ml fractions. The fractions containing active toxin, as identified by 
SDS-PAGE (a pair of bands around 65 kDa), were concentrated by centrifugation at 
3,500 rpm in Amicon® Ultra centrifugal filter devices with molecular weight cut off of 
50 kDa (Millipore). Phenylmethanesulfonylfluoride (PMSF) was added to 1 mM 
concentration to samples after activation by trypsinization to prevent excessive 
degradation. Sodium azide was added to “crystal washed” pellets that were to be stored 
overnight or longer to prevent bacterial growth. Purified toxin samples were stored at 
4°C. 
 
Mutant Toxicity Bioassays 
 
Mutant toxicity bioassays involved the analysis of percent mortality of Manduca 
sexta larvae across a concentration range. Two types of bioassay were performed, diet 
incorporation (WT and K490A) and surface treatment (WT, K478A, K403A, DM2), for 
reasons detailed in the results section. 1 ml tobacco hornworm growth media (www.bio-
serv.com), treated with the anti-fungal agent aureomycin, was aliquoted to each well of 
one 24-well polystyrene plate (2 cm2 wells, Falcon) per mutant strain. For the two, diet 
incorporation assay plates, 90.2-190.8 ul “Crystal Washed” insoluble protein suspension 
was incorporated into the hardening diet (50% normal agar added) across the 
concentrations 0, 15, 30, 60, 90, 120, and “lethal” (undiluted) ng/ml. For the four, surface 
treatment assay plates, 50 ul purified toxin dilution was added to the center of the 
hardened growth media across the concentrations 0, 1, 5, 10, 20, 30, and 50 ng/cm2. After 
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media and toxin were hardened and dry, two Manduca sexta larvae (neonate or 1st instar 
developmental stage, hatched from eggs purchased from Carolina Biological Supply 
Company) were added to each well such that four larvae were tested in both the highest 
and lowest (control) concentrations, and eight larvae were tested in all other 
concentrations. The number of living and dead larvae was recorded after 5, 8, and 11 
days. Pictures of the bioassay plates were taken after 11 days, prior to freezing at -20°C 
for disposal. 
 
Toxin Secondary Structural Analysis by Wavelength Scanning Circular Dichroism 
 
Toxin secondary structure was analyzed by wavelength scanning circular 
dichroism using an Aviv Circular Dichroism Spectrometer (Model 62A DS) for WT, 
K478A, K490A, K403A, and DM2. Toxin samples stored in 0.5 M NaCl 50 mM Na2CO3 
buffer, pH 10.5, were loaded to PD-10 Desalting Columns (GE Healthcare) and eluted 
with 50 mM Na2CO3 buffer, pH 10.5. Ten scans were averaged across the 195-300 nm 
wavelength range sampling every 1.0 nm, with 300 ul sample volumes at a concentration 
of 2 µM. 
 
Results 
 
Expression and Purification of Toxin Mutants 
 
Successful transformation of mutagenized Cry1Ab genes to chemically competent 
DH5α cells via the PBluescript vector was confirmed by plasmid preparation and 
sequencing at the Plant Microbe Genomics Facility (The Ohio State University, 
Columbus Campus). Expression of the mutant toxin was confirmed by the presence of a 
130 kDa band on an 8% SDS-polyacrylamide gel that was replaced by a pair of bands 
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(likely the result of multiple trypsin sites at the C-terminus of the activated toxin) at 65 
kDa after activation by trypsin digestion. An early mutant strain, dubbed S41C, 
containing the mutations K478A, K490A, and S41C was found to be sensitive to the 
purification procedure, disappearing entirely after trypsinization as shown in Figure 2 
(The molecular weight marker shown in this figure is the same throughout all SDS-
PAGE gels). Suspecting lysine mutagenesis to be the factor leading to this trait, the 
mutant toxins K478A, DM1 (K478A, K490A), TM (K478A, K490A, and K403A), and 
the WT toxin were solubilized for 3 hours, trypsinizing a sample of each for 30 minutes 
after each hour. Figure 3 shows that regardless of the time spent solubilizing the toxin, it 
is the addition of the K490A mutation that results in the loss of toxin. Bradford assays 
run during this procedure indicated a ~2.7 fold decrease in total protein from the wild 
type to the single mutant K478A, and a ~1.8 fold decrease in total protein from the single 
mutant K478A to the double mutant DM1, but no significant change in concentration 
between the double and triple mutant.  
After identifying the problematic mutation, single and double mutants (K478A, 
K490A, K403A, DM1 (K478A, K490A), and DM2 (K478A, K403A) were grown to 
more fully characterize the observations from previous mutants. Figure 4 shows the 
effects of the K490A mutation, both as a single mutant and in DM1.  
 
Mutant Toxicity Bioassays 
 
Mutant toxicity, interpreted as percent mortality, was recorded after 5, 8, and 11 
days taking pictures of the bioassay plates on the 11th day. WT and K490A toxins were 
compared by diet incorporation of the “crystal washed” pellet protein extract, as the intact 
form of K490A was difficult to obtain, but should still be toxic when ingested in this 
 11 
form. WT, K478A, K403A, and DM2 were compared by surface treatment. Diet 
incorporation assays were generally unsuccessful in establishing the typical 
proportionality between increasing concentration and percent mortality, probably because 
actual toxin concentrations are difficult to estimate in the mixture of protein crystals 
added. The most interesting data obtained from these plates was with respect to the four 
larvae treated at very high (undiluted) crystal concentrations, of which 75% died for the 
WT toxin and 100% died for K490A, suggesting the K490A is still toxic.  
The clearest data were achieved after 5 days and are described in Figure 5. These 
data show a general increase in percent mortality with an increase in the surface 
concentration of the toxin, particularly for the WT and K478A toxins. K403A and DM2 
toxins showed no significant trend in percent mortality with respect to surface 
concentration, which could be an indication of disrupted function or complications in 
assay preparation. Significant, however, is the appearance of the larvae after 11 days. 
Regardless of survival rate, a noticeable inverse relationship between toxin concentration 
and larval development can be observed in Figure 6, suggesting that the larvae had 
ingested enough toxin to cripple their metabolic functions, at which point their eating 
behavior ceased and they began to slowly starve to death. This could indicate that all 
toxin variants still maintain some degree of toxicity.  
 
Toxin Secondary Structural Analysis by Wavelength Scanning Circular Dichroism 
 
Secondary structural analysis by wavelength scanning circular dichroism was 
performed for WT, K478A, K403A, and DM2 toxins at 2 µM and K490A at 1.8 µM. 
Problematic toxin preparation of K490A, as described above, has prevented analysis of 
K490A at 2 µM up to this point. These data are shown in Figure 7, which shows the most 
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significant structural perturbations for K490A and DM2 where K478A and K403A show 
curves that describe structural elements similar to that of the WT toxin. K490A’s 
spectrum shows a decrease in overall alpha helical character, and DM2’s spectrum may 
suggest a decrease in alpha helical tertiary interactions. As significant amounts of active 
DM1 could not be purified and isolated, this mutant was not analyzed by wavelength 
scanning circular dichroism.  
 
Discussion 
 
From the results observed during protein purification of S41C, K490A, and DM1 
(Figures 2-4), the mutation of lysine 490 to an alanine disrupts the stability and total 
yield of the activated toxin. Considering that the DNA and expression vector, as well as 
the promoter from which the modified Cry1Ab gene was expressed, was the same as the 
WT for each mutant, it is unlikely that the mRNA expression of the gene has been 
reduced. It has been previously noted that certain mutations can lead to mutant protoxins 
and/or toxins that cannot be isolated, potentially due to an increase in protease sensitivity 
or access to protease sites as a result of alterations in the protein stability or structure 
(13). This observation correlates well with the data in Figure 7, showing K490A, which 
had the lowest yield, to be the most destabilized structure.  
Looking at the SDS-PAGE gels shown in Figures 2-4, it is apparent that the 
mutation K490A has a significant effect on the stability of the toxin. Frames A and B of 
Figure 2 show that S41C protoxin could be solubilized, but after trypsinization (lane 2, 
frame B), the active toxin band (65 kDa) is not seen. Instead, a pair of dark bands, that 
can also be observed in the WT prep in Figure 2 Frame D, appear below the 37 kDa 
marker. These bands may represent degraded fragments of the active toxin. Though one 
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may not expect removal of a lysine (potential trypsin cleavage site) to increase the extent 
of cleavage, my supposition is that alteration of the toxin’s structure, due to destabilizing 
effects as a result of the K490A mutation, may expose other trypsin sites or sites sensitive 
to cleavage by other proteases. Figure 3 shows that regardless of the time spent 
solubilizing the protein pellet, addition of the K490A mutation has, at lease visibly, 
prevented isolation of even the protoxin. Though yield was decreased by addition of each 
successive mutation (except for the 3rd and final mutation, K403A), it is noted that the 
visible presence of bands running at molecular weight 50 kDa and smaller suggests that 
these are the principle species, and the visible absence of protoxin and toxin bands is not 
due to an overall lack of protein. Though protein concentration from left to right across 
these gels decreases, these bands remain present, indicating that their relative amount is 
increasing with respect to protoxin and toxin. It must also be noted that particularly for 
TM, and a lesser extent for DM1, the same pair of bands below the 37 kDa marker can be 
seen as was observed in Figure 2. These < 50 kDa bands appear to be present, at least to 
some degree, in all lanes of Figure 3, Frame B, suggesting that these bands are possible 
degradation products of Cry1Ab.  
These observations are reiterated in Figure 4, which represents separate 
preparations of the K490A and DM1 mutant toxins. Frame A shows a band just below the 
75 kDa marker in lanes 2 and 3 that is likely an already partially degraded form of the 
protoxin, that is partially converted to the active form after trypsinization (lane 3). Odd, 
however, is the almost complete absence of protein in lanes 4 and 5 (after ion exchange 
column purification). Frame B shows the end result of this K490A prep from which a 
small amount of K490A was successfully purified, but in the presence of the degraded 
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bands < 50 kDa. Frame C representing the purification of DM1 first shows in lane 1 the 
purified form of DM2 active toxin as a reference for a stably prepared double lysine 
mutant. The remaining lanes show the purification of DM1 in which the above 
observations can be seen again as the protein concentration density shifts away from 
larger species like the protoxin and toxin toward the degraded bands around or below 50 
kDa. As the difficulty experienced in purifying K490A containing mutants seems to be 
related to protease sensitivity, any future attempts at purification of such mutants should 
analyze the effect of shorter trypsin digestions and more delicate storage and handling 
techniques.  
Bioassay experiments performed in this study showed a clear proportionality 
between percent mortality and toxin surface concentration 5 days after treatment, as 
shown in Figure 5, and as previously observed (11). Though percent mortality 
calculations for the diet incorporation assays were not useful for analysis, the observation 
that the undiluted crystals were still lethal lends credence to the likelihood of K490A’s 
toxicity. The photographs of the six bioassay plates shown in Figure 6 show a clear 
inhibition of larval growth and development as toxin concentrations increase from left to 
right (highest and lowest (0) concentrations, however, are the first column of four wells, 
highest being the top two and lowest being the bottom two), as has previously been 
observed for Cry1Ab (14). These plates support the conclusion that the toxins studied 
may have lost some degree of toxicity relative to the WT, but are still functional. 
Wavelength scanning circular dichroism is a tool that is commonly used to 
analyze protein secondary and/or tertiary structures (http://www.ap-
lab.com/circular_dichroism.htm). The dominant form of secondary structure in Cry1Ab is 
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the alpha helix (as can been seen in Figure 1, Frame A), and the observed elipticity 
response spectra shown in Figure 7 generally agree with a predominantly alpha helical 
structure. The patterns observed in Figure 7 for WT with respect to the mutants K478A 
and K403A shows only minor deviations in secondary structure, indicating that these 
mutants have a secondary structure similar to that of the WT toxin. K490A’s CD 
spectrum shows an upward shift in elipticity, and a softening of the two alpha helical 
minima typically found at 220 and 208 nm (15). This could be an indication of a loss of 
secondary structural elements in conjunction with a spectral shift toward a structure with 
more random coil nature, but could also be related to the lower concentration analyzed by 
necessity, as described earlier. If K490A’s CD spectrum is, in fact, an indication of an 
increase in random secondary structure, it could explain the apparent increase in protease 
sensitivity for this mutant. DM2’s CD spectrum shows a shift in the opposite direction, 
particularly around wavelength 208 nm, which may be an indication that the mutations of 
DM2 have led to a decrease in tertiary interactions of alpha helices (16).  
Thermal denaturation of Cry1Ab toxins can be observed by circular dichroism 
signal at 223 nm and reflects the thermal stability of the protein (17). Preliminary work in 
an effort to achieve this data has been done (Figure 8 Frame A), but an SDS-PAGE gel 
(Figure 8 Frame B) has shown the WT toxin used for this data was degraded. Significant 
levels of impurities preclude this data from speculation until reliable WT data can be 
achieved. 
Figure 9 shows the successfully purified forms of each toxin analyzed in this 
study. Following the same procedure in each preparation, K490A and DM1 mutants 
could not be purified as was the case with other single or double mutants. Based on the 
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combined results of SDS-PAGE analysis, bioassay, and circular dichroism wavelength 
scanning, I would conclude that the K490A mutation, whether alone or in combination 
with the K478A mutation, yields a toxin with a secondary structure similar to that of the 
WT, but perhaps loose enough in conformational flexibility that cellular proteases, as 
well as the protease treatment procedurally applied in toxin activation, digest the protein 
to fragments < 50 kDa before useable quantities can be isolated.  
Looking back at the work described in this study, it has become clear to me that 
lysine 490 should not be mutated to alanine. This, however, does not mean that it cannot 
be used for fluorophore ligation. The next step in my research will be an analysis of the 
accessibility and binding of fluorescent tags to unmutated Cry1Ab toxin. It is my 
prediction that lysine 478 may not be accessible to amine reactive ligation, where lysines 
490 and 403 will likely be accessible. If this is the case, lysine 478 may not need to be 
removed, reducing the structural stress of creating double mutants. As lysine 490 should 
be left unmutated, a K403A mutant could then provide a single, accessible lysine for 
fluorophore ligation. If this succeeds, and the structure of the fluorophore ligated toxin 
can be shown to be close to the WT structure, cysteine mutants could be developed by a 
similar process to provide the other fluorophore ligation site necessary for FRET 
analysis.  
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Figures 
 
Figure 1: Location of lysine residues within Cry1Ab structure (based on PDB file 1CIY 
for Cry1Aa) 
 
A      B 
 
 
Frame A: Cartoon model showing positions of lysine 403 (bottom), 478 (top), and 490    
     (left) with domain I in blue, domain II in green, and domain III in red 
Frame B: Spacefilling model with the same color coding to illustrate the relative depths  
of the three lysines with 478 buried, 490 exposed in a pocket, and 403 surface   
level 
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Figure 2: S41C Purification Analysis 
 
A   B 
     1      2     3                1     2      3     4 
 
 
Frame A: Lane (1) MW marker (2) 1/10 dilution solubilized S41C (3) solubilized S41C 
Frame B: Lane (1) MW marker (2) trypsinized S41C (3) S41C ion exchange column flow   
through (4) S41C ion exchange column elution 
 
 
C      D 
        1      2      3      4      5                1     2      3      4     5     6      7     8 
 
     
 
Frame C: Lane (1) solubilized S41C (2) ½ dilution solubilized S41C (3) MW marker (4) 
½ dilution solubilized WT (5) solubilized WT 
Frame D: Lane (1) 1/10 dilution solubilized S41C (2) solubilized S41C (3) trypsinized 
S41C (4) MW marker (5) 1/10 dilution solubilied WT (6) trypsinized WT (7) 
WT ion exchange column flow through (8) WT ion exchange column eluant  
 
 
 
150 
100 
 75 
 50 
 37 
kDa  
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Figure 3: Solubilization and trypsinization of successive lysine deletions over time 
 
Frame A: Lane (1) MW marker (2,3) WT solubilization/trypsinization (4,5) K478A 
solubilization/trypsinization (6,7) DM1 solubilization/trypsinization (8,9) TM 
solubilization trypsinization all after 1 hour solubilization 
 
         1    2     3      4      5     6    7      8     9 
 
 
 
 
Frame B: Lane (1) MW marker (2,3) WT solubilization/trypsinization (4,5) K478A 
solubilization/trypsinization (6,7) DM1 solubilization/trypsinization (8,9) TM 
solubilization trypsinization all after 2 hour solubilization 
 
         1    2      3     4     5     6    7      8     9 
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Frame C: Lane (1) MW marker (2,3) WT solubilization/trypsinization (4,5) K478A 
solubilization/trypsinization (6,7) DM1 solubilization/trypsinization (8,9) TM 
solubilization trypsinization all after 3 hour solubilization 
 
       1     2      3     4      5      6     7     8     9 
 
 
 
Figure 4: Purification of K490A and DM1  
 
A   B   C 
 
      1              2       3       4     5          1      2     3          1      2       3       4      5       6 
 
 
 
 
Frame A: Lane (1) MW marker (2) 1/10 dilution K490A solubilization (3) K490A 
trypsinization (4) ion exchange column flow through (5) ion exchange column 
eluant 
Frame B: Lane (1) MW marker (2) purified K490A in 0.0 M NaCl 50 mM Na2CO3 
buffer, pH 10.5 (3) purified K490A in 0.5 M NaCl 50 mM Na2CO3 buffer, pH 
10.5 
Frame C: Lane (1) purified DM2 in 0.0 M NaCl 50 mM Na2CO3 buffer, pH 10.5 (2) MW 
marker (3) 1/10 dilution DM1 solubilization (4) DM1 trypsinization (5) ion 
exchange column flow through (6) ion exchange column eluant 
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Figure 5: Surface treatment bioassay mortality 5 days after treatment 
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Figure 6: Photographs of bioassay plates 11 days after treatment 
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Figure 7: Mutant toxin wavelength scanning circular dichroism spectra 
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Figure 8: Mutant toxin thermal denaturation analyzed by circular dichroism at 223 nm 
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Frame B: Lane (1) purified WT toxin (2) purified K478A (3) MW marker (4) purified 
K403A (5) purified DM2 
 
             1      2     3      4      5 
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Figure 9: Purified toxin variants 
 
Frame A: lane (1) purified K478A (2) desalted K478A CD sample; resalted (3,4) K490A 
CD sample and storage sample (5) MW marker (6) desalted K403A CD sample; 
resalted (7) unconcentrated combination of K403A gel filtration column 
fractions (8) purified DM1 (9) desalted DM2 CD sample; resalted (10) purified 
DM2 
 
Frame B: lane (1) concentration of two WT gel filtration column fractions (2)     
concentration of three WT gel filtration column fractions (3) concentration of 
Frame A lane 7 (4) MW marker 
 
 
A       B 
 
    1     2      3     4     5      6      7     8     9     10                   1       2       3     4 
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